Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?

BACKGROUND: In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly prescribed to adults with congenital heart disease (CHD) and atrial arrhythmias without good evidence for either safety or efficacy. To address this gap, we initiated an ongoing prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hayang, Bouma, Berto J., Mulder, Barbara J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591797/
https://www.ncbi.nlm.nih.gov/pubmed/28785894
http://dx.doi.org/10.1007/s10557-017-6745-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591797/
https://www.ncbi.nlm.nih.gov/pubmed/28785894
http://dx.doi.org/10.1007/s10557-017-6745-y

Ejemplares similares